Skip to main content
. 2020 May 21;9(5):1276. doi: 10.3390/cells9051276

Figure 6.

Figure 6

Hemodynamic studies of PAH without or with silibinin treatment. (A,B) Silibinin did not decrease RVSP (A) and the Fulton index (B) after two weeks of treatment in the normal-silibinin group compared to the normal-control group. (C,D) Silibinin significantly decreased RVSP (C) and the Fulton index (D) after two weeks of treatment in the PAH-silibinin group compared to the PAH-control group. * p < 0.05. Each group consisted of four rats.